Sandoz Egypt Partners Up To Launch Rituximab Biosimilar

Projected Savings For NHL Estimated At 40%

 
• By Dean Rudge
  
Middle East
The launch 'represents a clear added value to the treatment of blood cancers in Egypt,' Sandoz says • Source: Shutterstock

More from Biosimilars

More from Products